• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

24岁时与肝脂肪变性相关的儿童和青少年期丙氨酸氨基转移酶变化趋势:一项基于英国人群的队列研究

ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.

作者信息

Sekkarie Ahlia, Welsh Jean A, Northstone Kate, Cioffi Catherine E, Stein Aryeh D, Figueroa Janet, Ramakrishnan Usha, Vos Miriam B

机构信息

Laney Graduate School, Emory University, Atlanta, GA 30322, USA.

Department of Pediatrics, Emory School of Medicine, Atlanta, GA 30322, USA.

出版信息

Children (Basel). 2020 Sep 1;7(9):117. doi: 10.3390/children7090117.

DOI:10.3390/children7090117
PMID:32882815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7552746/
Abstract

(1) Background: Alanine aminotransferase (ALT) is used to screen for non-alcoholic fatty liver disease (NAFLD) in children; however, the optimal age to commence screening is not determined. Our objective was to describe whether ALT trends from 9-24 years were associated with hepatic steatosis at 24 years in a population-based UK cohort. (2) Methods: The sample included 1156 participants who were assessed for hepatic steatosis at 24 years and had at least two ALT measurements at 9, 15, 17, and/or 24 years. Controlled attenuation parameter scores were used to assess steatosis (low (<248 dB/m), mild/moderate (248-279 dB/m), severe (>279 dB/m)). Sex-stratified mixed-effects models were constructed to assess the liver enzyme trends by steatosis level. (3) Results: The final sample was 41.4% male and 10.4% had severe steatosis. In both sexes, ALT trends from 9 to 24 years differed in those with low vs. severe steatosis at 24 years ( < 0.001). There was no evidence of differences prior to puberty. At 17 years, the low vs. severe geometric mean ratio (GMR) was 0.69, 95% CI: 0.57-0.85 in males and (0.81, 0.65-1.01) females. At 24 years, the GMR was (0.53, 0.42-0.66) in males and (0.67, 0.54-0.84) females. (4) Conclusions: Higher ALT concentration in adolescence was associated with hepatic steatosis at 24 years. The increased screening of adolescents could strengthen NAFLD prevention and treatment efforts.

摘要

(1) 背景:丙氨酸氨基转移酶(ALT)用于筛查儿童非酒精性脂肪性肝病(NAFLD);然而,开始筛查的最佳年龄尚未确定。我们的目标是描述在英国一个基于人群的队列中,9至24岁的ALT变化趋势是否与24岁时的肝脂肪变性有关。(2) 方法:样本包括1156名参与者,这些参与者在24岁时接受了肝脂肪变性评估,并在9岁、15岁、17岁和/或24岁时至少进行了两次ALT测量。使用受控衰减参数评分来评估脂肪变性(低(<248 dB/m)、轻度/中度(248 - 279 dB/m)、重度(>279 dB/m))。构建性别分层的混合效应模型,以按脂肪变性水平评估肝酶变化趋势。(3) 结果:最终样本中男性占41.4%,10.4%有重度脂肪变性。在男女两性中,24岁时脂肪变性程度低与重度的人群,其9至24岁的ALT变化趋势存在差异(<0.001)。青春期前没有差异的证据。在17岁时,男性中脂肪变性程度低与重度的几何平均比(GMR)为0.69,95%置信区间:0.57 - 0.85,女性为(0.81,0.65 - 1.01)。在24岁时,男性的GMR为(0.53,0.42 - 0.66),女性为(0.67,0.54 - 0.84)。(4) 结论:青少年时期较高的ALT浓度与24岁时的肝脂肪变性有关。增加对青少年的筛查可以加强NAFLD的预防和治疗工作。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/7552746/b44e860a424d/children-07-00117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/7552746/44d9596afe72/children-07-00117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/7552746/282f5c0b55d2/children-07-00117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/7552746/b44e860a424d/children-07-00117-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/7552746/44d9596afe72/children-07-00117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/7552746/282f5c0b55d2/children-07-00117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c8f/7552746/b44e860a424d/children-07-00117-g003.jpg

相似文献

1
ALT Trends through Childhood and Adolescence Associated with Hepatic Steatosis at 24 Years: A Population-Based UK Cohort Study.24岁时与肝脂肪变性相关的儿童和青少年期丙氨酸氨基转移酶变化趋势:一项基于英国人群的队列研究
Children (Basel). 2020 Sep 1;7(9):117. doi: 10.3390/children7090117.
2
Diagnostic Accuracy and Optimal Cut-off of Controlled Attenuation Parameter for the Detection of Hepatic Steatosis in Indian Population.印度人群中用于检测肝脂肪变性的受控衰减参数的诊断准确性及最佳临界值
J Clin Exp Hepatol. 2022 May-Jun;12(3):893-898. doi: 10.1016/j.jceh.2021.10.003. Epub 2021 Oct 13.
3
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.英国年轻人脂肪性肝病和肝纤维化的流行情况:一项基于人群的研究。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):295-305. doi: 10.1016/S2468-1253(19)30419-4. Epub 2020 Jan 15.
4
Transient elastography for the prevalence of non-alcoholic fatty liver disease in patients with type 2 diabetes: Evidence from the CORDIAL cohort study.瞬时弹性成像用于评估 2 型糖尿病患者非酒精性脂肪性肝病的患病率:来自 CORDIAL 队列研究的证据。
Saudi J Gastroenterol. 2022 Nov-Dec;28(6):426-433. doi: 10.4103/sjg.sjg_73_22.
5
[Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].超声衰减参数在代谢功能障碍相关脂肪性肝病诊断中的应用研究
Zhonghua Gan Zang Bing Za Zhi. 2022 Mar 20;30(3):290-296. doi: 10.3760/cma.j.cn501113-20210826-00428.
6
Longitudinal associations of total and trunk fat in childhood and adolescence and risk of hepatic steatosis at 24 years.儿童和青少年时期全身和躯干脂肪与 24 岁时肝脂肪变性风险的纵向关联。
Pediatr Obes. 2021 Aug;16(8):e12773. doi: 10.1111/ijpo.12773. Epub 2021 Feb 8.
7
Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients.用于评估印度患者肝脂肪变性的受控衰减参数
J Clin Exp Hepatol. 2019 Jan-Feb;9(1):13-21. doi: 10.1016/j.jceh.2018.02.010. Epub 2018 Mar 14.
8
Association Between Hepatic Steatosis, Measured by Controlled Attenuation Parameter, and Fibrosis Burden in Chronic Hepatitis B.受控衰减参数评估的肝脂肪变与慢性乙型肝炎肝纤维化程度的相关性。
Clin Gastroenterol Hepatol. 2018 Apr;16(4):575-583.e2. doi: 10.1016/j.cgh.2017.09.044. Epub 2017 Sep 29.
9
Body mass index-based controlled attenuation parameter cut-offs for assessment of hepatic steatosis in non-alcoholic fatty liver disease.基于体重指数的控制衰减参数临界值在非酒精性脂肪性肝病肝脂肪变评估中的应用
Indian J Gastroenterol. 2020 Feb;39(1):32-41. doi: 10.1007/s12664-019-00991-2. Epub 2020 Mar 17.
10
The Role of Metabolic Factors and Steatosis in Treatment-Naïve Patients with Chronic Hepatitis B and Normal Alanine Aminotransferase.代谢因素和脂肪变性在初治慢性乙型肝炎且丙氨酸氨基转移酶正常患者中的作用
Infect Dis Ther. 2022 Jun;11(3):1133-1148. doi: 10.1007/s40121-022-00629-5. Epub 2022 Apr 10.

引用本文的文献

1
Triglyceride-glucose-alanine aminotransferase index: A noninvasive serum predictor for identifying the severity of pediatric nonalcoholic fatty liver disease.甘油三酯-葡萄糖-丙氨酸转氨酶指数:一种用于识别小儿非酒精性脂肪性肝病严重程度的非侵入性血清预测指标。
Medicine (Baltimore). 2024 Jun 28;103(26):e38241. doi: 10.1097/MD.0000000000038241.
2
Relationship between triglyceride-glucose index and aminotransferase among Royal Thai Army personnel 2017-2021: a serial cross-sectional study.2017-2021 年泰国皇家陆军人员的甘油三酯-葡萄糖指数与转氨酶之间的关系:一项连续横断面研究。
Lipids Health Dis. 2023 Apr 3;22(1):47. doi: 10.1186/s12944-023-01811-5.
3

本文引用的文献

1
Prevalence of steatosis and fibrosis in young adults in the UK: a population-based study.英国年轻人脂肪性肝病和肝纤维化的流行情况:一项基于人群的研究。
Lancet Gastroenterol Hepatol. 2020 Mar;5(3):295-305. doi: 10.1016/S2468-1253(19)30419-4. Epub 2020 Jan 15.
2
The REDCap consortium: Building an international community of software platform partners.REDCap 联盟:构建软件平台合作伙伴的国际社区。
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
3
The Avon Longitudinal Study of Parents and Children (ALSPAC): an update on the enrolled sample of index children in 2019.
Updated reference ranges for aminotransferase levels of Korean children and young adolescents based on the risk factors for metabolic syndrome.
基于代谢综合征相关危险因素的韩国儿童和青少年氨基转移酶水平参考范围更新。
Sci Rep. 2022 Sep 21;12(1):15739. doi: 10.1038/s41598-022-20104-y.
4
Stratification by obesity class, rather than age, can identify a higher percent of children at risk for non-alcoholic fatty liver disease and metabolic dysfunction.按肥胖程度分层,而不是按年龄分层,可以确定更高比例的儿童有患非酒精性脂肪肝和代谢功能障碍的风险。
Pediatr Obes. 2022 Mar;17(3):e12862. doi: 10.1111/ijpo.12862. Epub 2021 Oct 18.
5
Associations of maternal diet and nutritional status with offspring hepatic steatosis in the Avon longitudinal study of parents and children.在雅芳亲子纵向研究中,母亲饮食与营养状况与后代肝脏脂肪变性的关联。
BMC Nutr. 2021 Jul 8;7(1):28. doi: 10.1186/s40795-021-00433-3.
6
Decreased Muscle-to-Fat Mass Ratio Is Associated with Low Muscular Fitness and High Alanine Aminotransferase in Children and Adolescent Boys in Organized Sports Clubs.在有组织的体育俱乐部中,儿童和青少年男性肌肉与脂肪质量比降低与低肌肉适应性和高丙氨酸转氨酶有关。
J Clin Med. 2021 May 24;10(11):2272. doi: 10.3390/jcm10112272.
雅芳亲子纵向研究(ALSPAC):2019年研究对象儿童登记样本的最新情况
Wellcome Open Res. 2019 Mar 14;4:51. doi: 10.12688/wellcomeopenres.15132.1. eCollection 2019.
4
Data on trajectories of measures of cardiovascular health in the Avon Longitudinal Study of Parents and Children (ALSPAC).埃文亲子纵向研究(ALSPAC)中关于心血管健康指标轨迹的数据。
Data Brief. 2019 Jan 19;23:103687. doi: 10.1016/j.dib.2019.01.035. eCollection 2019 Apr.
5
Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial.低糖饮食与常规饮食对青少年非酒精性脂肪肝的影响:一项随机临床试验。
JAMA. 2019 Jan 22;321(3):256-265. doi: 10.1001/jama.2018.20579.
6
AUDIT and AUDIT-C as screening instruments for alcohol problem use in adolescents.AUDIT 和 AUDIT-C 作为青少年酒精问题使用的筛查工具。
Drug Alcohol Depend. 2018 Jul 1;188:266-273. doi: 10.1016/j.drugalcdep.2018.04.015. Epub 2018 May 19.
7
New pediatric percentiles of liver enzyme serum levels (alanine aminotransferase, aspartate aminotransferase, γ-glutamyltransferase): Effects of age, sex, body mass index, and pubertal stage.新的儿童血清肝酶水平(丙氨酸氨基转移酶、天冬氨酸氨基转移酶、γ-谷氨酰转移酶)百分位数:年龄、性别、体重指数和青春期阶段的影响。
Hepatology. 2018 Oct;68(4):1319-1330. doi: 10.1002/hep.29542. Epub 2018 May 16.
8
Severe Fat Accumulation in Multiple Organs in Pediatric Autopsies: An Uncommon but Significant Finding.小儿尸检中多器官严重脂肪堆积:一项罕见但重要的发现。
Pediatr Dev Pathol. 2017 Jul-Aug;20(4):269-276. doi: 10.1177/1093526617691708. Epub 2017 Feb 6.
9
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.非酒精性脂肪性肝病作为一种性别差异疾病:性别和生殖状态在非酒精性脂肪性肝病发生发展及内在心血管风险中的作用
Adv Ther. 2017 Jun;34(6):1291-1326. doi: 10.1007/s12325-017-0556-1. Epub 2017 May 19.
10
NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).NASPGHAN儿童非酒精性脂肪性肝病诊断与治疗临床实践指南:非酒精性脂肪性肝病专家委员会(ECON)及北美儿科胃肠病学、肝病学和营养学会(NASPGHAN)的建议
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):319-334. doi: 10.1097/MPG.0000000000001482.